Leah McCartt, MD
Child & Adolescent Psychiatry · Greenville, SCNPI 1861551285
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $382 and has fallen 93.8% since, to $24 in 2025.
Across 37 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$154
- Otsuka America Pharmaceutical, Inc.$139
- Johnson & Johnson$108
- Ironshore Pharmaceuticals Inc.$53
- Sunovion Pharmaceuticals Inc.$50
- Alkermes, Inc.$48
- plus $107 from 5 others
What the payments were for
- Food & beverage$658100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 5 | $154 |
| Otsuka America Pharmaceutical, Inc. | 8 | $139 |
| Johnson & Johnson | 7 | $108 |
| Ironshore Pharmaceuticals Inc. | 3 | $53 |
| Sunovion Pharmaceuticals Inc. | 5 | $50 |
| Alkermes, Inc. | 3 | $48 |
| AbbVie | 2 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Corium, LLC | 1 | $22 |
| Adlon Therapeutics L.p. | 1 | $21 |
| Neos Therapeutics, LP | 1 | $16 |
How this compares
$658 in reported general payments places this provider in the 60th percentile of 71 child & adolescent psychiatry providers in South Carolina.
See all child & adolescent psychiatry providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $418 |
| Bupropion XlBupropion Hcl | 18 | $256 |
| Mirtazapine | 11 | $161 |
| Duloxetine Hcl | 15 | $160 |
| Trazodone Hcl | 23 | $158 |
| Quetiapine Fumarate | 13 | $87 |
| Gabapentin | 16 | $87 |
| Sertraline Hcl | 12 | $59 |
| Clonazepam | 30 | $50 |
| Escitalopram Oxalate | 12 | $47 |
| Lamotrigine | 16 | $43 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Greenville
- David SherbondyGreenville$19K
- Elena DlugachGreenville$8K
- Brittany RodgersGreenville$3K
- Elizabeth MasonGreenville$1K
- Deborah DavisGreenville$999
- Michael SierraGreenville$483
- Amy JonesGreenville$282
- Sara Infield LavelleGreenville$224
- Lance FeldmanGreenville$190
- Dinorah GomezGreenville$150
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.